Serial plasma metabolites following hypoxic-ischemic encephalopathy in a nonhuman primate model

Developmental Neuroscience

Volumn 37, Issue 2, 2015, Pages 161-171

  Chun, Pattaraporn T ^a   McPherson, Ronald J ^a   Marney, Luke C ^b   Zangeneh, Sahar Z ^c   Parsons, Brendon A ^b   Shojaie, Ali ^b   Synovec, Robert E ^b   Juul, Sandra E ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Hypoxic ischemic encephalopathy; Metabolomics; Neuroprotection; Nonhuman primate; Perinatal asphyxia

Indexed keywords

ALANINE; AMINOMALONIC ACID; ARACHIDONIC ACID; BIOLOGICAL MARKER; BUTYRIC ACID; CITRIC ACID; ERYTHROPOIETIN; FUMARIC ACID; GLUCOSE; GLUTAMIC ACID; INOSITOL; LACTIC ACID; LEUCINE; MALIC ACID; MALONIC ACID; NORVALINE; PANTOTHENIC ACID; PHENYLALANINE; PROPIONIC ACID; SERINE; STEARIC ACID; SUCCINIC ACID; TYROSINE; UNCLASSIFIED DRUG; VALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APGAR SCORE; ARTICLE; BIRTH; BLOOD PH; BRADYCARDIA; BRAIN DEVELOPMENT; BRAIN INJURY; CELL METABOLISM; CEREBRAL PALSY; CONTROLLED STUDY; FEMALE; HYPOXIC ISCHEMIC ENCEPHALOPATHY; INDUCED HYPOTHERMIA; LACTATE BLOOD LEVEL; MACACA NEMESTRINA; MALE; METABOLOME; METABOLOMICS; NEWBORN; NONHUMAN; PERINATAL ASPHYXIA; PREDICTION; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; UPREGULATION; ANIMAL; BLOOD; COMPLICATION; DISEASE MODEL; HYPOTHERMIA; INJURIES; NEWBORN HYPOXIA; PHYSIOLOGY; UMBILICAL CORD;

ANIMALS; ANIMALS, NEWBORN; APGAR SCORE; ASPHYXIA NEONATORUM; BIOMARKERS; CEREBRAL PALSY; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN; FEMALE; HYPOTHERMIA; HYPOXIA-ISCHEMIA, BRAIN; MACACA NEMESTRINA; MALE; METABOLOME; UMBILICAL CORD;

EID: 84928622399     PISSN: 03785866     EISSN: 14219859     Source Type: Journal    
DOI: 10.1159/000370147     Document Type: Article

References (43)

1. Kurinczuk JJ, White-Koning M, Badawi N: Epidemiology of neonatal encephalopathy and hypoxic-ischaemic encephalopathy. Early Hum Dev 2010; 86: 329-338.
2. Graham EM, Ruis KA, Hartman AL, Northington FJ, Fox HE: A systematic review of the role of intrapartum hypoxia-ischemia in the causation of neonatal encephalopathy. Am J Obstet Gynecol 2008; 199: 587-595.
3. Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, Jha P, Campbell H, Walker CF, Cibulskis R, Eisele T, Liu L, Mathers C: Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet 2010; 375: 1969-1987.
4. Tagin MA, Woolcott CG, Vincer MJ, Whyte RK, Stinson DA: Hypothermia for neonatal hypoxic-ischemic encephalopathy: an updated systematic review and meta-analysis. Arch Pediatr Adolesc Med 2012; 166: 558-566.
5. Edwards AD, Brocklehurst P, Gunn AJ, Halliday H, Juszczak E, Levene M, Strohm B, Thoresen M, Whitelaw A, Azzopardi D: Neurological outcomes at 18 months of age after moderate hypothermia for perinatal hypoxic ischaemic encephalopathy: synthesis and meta-analysis of trial data. BMJ 2010; 340:c363.
6. Thornton C, Rousset CI, Kichev A, Miyakuni Y, Vontell R, Baburamani AA, Fleiss B, Gressens P, Hagberg H: Molecular mechanisms of neonatal brain injury. Neurol Res Int 2012; 2012: 506320.
7. Atzori L, Xanthos T, Barberini L, Antonucci R, Murgia F, Lussu M, Aroni F, Varsami M, Papalois A, Lai A, D'Aloja E, Iacovidou N, Fanos V: A metabolomic approach in an experimental model of hypoxia-reoxygenation in newborn piglets: urine predicts outcome. J Matern Fetal Neonatal Med 2010; 23(suppl 3): 134-137.
8. Beckstrom AC, Humston EM, Snyder LR, Synovec RE, Juul SE: Application of comprehensive two-dimensional gas chromatography with time-of-flight mass spectrometry method to identify potential biomarkers of perinatal asphyxia in a non-human primate model. J Chromatogr A 2011; 1218: 1899-1906.
9. Jacobson Misbe EN, Richards TL, McPherson RJ, Burbacher TM, Juul SE: Perinatal asphyxia in a nonhuman primate model. Dev Neurosci 2011; 33: 210-221.
10. Traudt CM, Juul SE: Erythropoietin as a neuroprotectant for neonatal brain injury: animal models. Methods Mol Biol 2013; 982: 113-126.
11. Beckstrom AC, Tanya P, Humston EM, Snyder LR, Synovec RE, Juul SE: The perinatal transition of the circulating metabolome in a nonhuman primate. Pediatr Res 2012; 71: 338-344.
12. Traudt CM, McPherson RJ, Bauer LA, Richards TL, Burbacher TM, McAdams RM, Juul SE: Concurrent erythropoietin and hypothermia treatment improve outcomes in a term nonhuman primate model of perinatal asphyxia. Dev Neurosci 2013; 35: 491-503.
13. Mohler RE, Tu BP, Dombek KM, Hoggard JC, Young ET, Synovec RE: Identification and evaluation of cycling yeast metabolites in twodimensional comprehensive gas chromatography-time-of-flight-mass spectrometry data. J Chromatogr A 2008; 1186: 401-411.
14. Hoggard JC, Synovec RE: Parallel factor analysis (PARAFAC) of target analytes in GC × GC-TOFMS data: automated selection of a model with an appropriate number of factors. Anal Chem 2007; 79: 1611-1619.
15. Humston EM, Dombek KM, Hoggard JC, Young ET, Synovec RE: Time-dependent profiling of metabolites from SNF1 mutant and wild-type yeast cells. Anal Chem 2008; 80: 8002-8011.
16. Mohler RE, Dombek KM, Hoggard JC, Young ET, Synovec RE: Comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry analysis of metabolites in fermenting and respiring yeast cells. Anal Chem 2006; 78: 2700-2709.
17. Bohannon RW, Smith MB: Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther 1987; 67: 206-207.
18. Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995: 289-300.
19. Fanos V, Antonucci R, Barberini L, Noto A, Atzori L: Clinical application of metabolomics in neonatology. J Matern Fetal Neonatal Med 2012; 25(suppl 1):104-109.
20. Liu J, Sheldon RA, Segal MR, Kelly MJ, Pelton JG, Ferriero DM, James TL, Litt L: 1 H nuclear magnetic resonance brain metabolomics in neonatal mice after hypoxia-ischemia distinguished normothermic recovery from mild hypothermia recoveries. Pediatr Res 2013; 74: 170-179.
21. Dessi A, Corsello G, Stronati M, Gazzolo D, Caboni P, Carboni R, Fanos V: New diagnostic possibilities in systemic neonatal infections: metabolomics. Early Hum Dev 2014; 90(suppl 1):S19-S21.
22. Fanos V, Noto A, Xanthos T, Lussu M, Murgia F, Barberini L, Finco G, d'Aloja E, Papalois A, Iacovidou N, Atzori L: Metabolomics network characterization of resuscitation after normocapnic hypoxia in a newborn piglet model supports the hypothesis that room air is better. Biomed Res Int 2014; 2014: 731620.
23. Arduini A, Escobar J, Vento M, Escrig R, Quintas G, Sastre J, Saugstad OD, Solberg R: Metabolic adaptation and neuroprotection differ in the retina and choroid in a piglet model of acute postnatal hypoxia. Pediatr Res 2014; 76: 127-134.
24. Skappak C, Regush S, Cheung PY, Adamko DJ: Identifying hypoxia in a newborn piglet model using urinary NMR metabolomic profiling. PLoS One 2013; 8:e65035.
25. Mussap M, Noto A, Fanos V, Van Den Anker JN: Emerging biomarkers and metabolomics for assessing toxic nephropathy and acute kidney injury (AKI) in neonatology. Biomed Res Int 2014; 2014: 602526.
26. Rao R, Ennis K, Oz G, Lubach GR, Georgieff MK, Coe CL: Metabolomic analysis of cerebrospinal fluid indicates iron deficiency compromises cerebral energy metabolism in the infant monkey. Neurochem Res 2013; 38: 573-580.
27. Connor SC, Hansen MK, Corner A, Smith RF, Ryan TE: Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes. Mol Biosyst 2010; 6: 909-921.
28. Fanos V, Antonucci R, Barberini L, Atzori L: Urinary metabolomics in newborns and infants. Adv Clin Chem 2012; 58: 193-223.
29. Noto A, Mussap M, Fanos V: Is 1 H NMR metabolomics becoming the promising early biomarker for neonatal sepsis and for monitoring the antibiotic toxicity? J Chemother 2014; 26: 130-132.
30. Fanos V, Caboni P, Corsello G, Stronati M, Gazzolo D, Noto A, Lussu M, Dessi A, Giuffre M, Lacerenza S, Serraino F, Garofoli F, Serpero LD, Liori B, Carboni R, Atzori L: Urinary 1 H-NMR and GC-MS metabolomics predicts early and late onset neonatal sepsis. Early Hum Dev 2014; 90(suppl 1):S78-S83.
31. Solberg R, Enot D, Deigner HP, Koal T, Scholl-Burgi S, Saugstad OD, Keller M: Metabolomic analyses of plasma reveals new insights into asphyxia and resuscitation in pigs. PLoS One 2010; 5:e9606.
32. Sapieha P, Sirinyan M, Hamel D, Zaniolo K, Joyal JS, Cho JH, Honore JC, Kermorvant-Duchemin E, Varma DR, Tremblay S, Leduc M, Rihakova L, Hardy P, Klein WH, Mu X, Mamer O, Lachapelle P, Di Polo A, Beausejour C, Andelfinger G, Mitchell G, Sennlaub F, Chemtob S: The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis. Nat Med 2008; 14: 1067-1076.
33. Hamel D, Sanchez M, Duhamel F, Roy O, Honore JC, Noueihed B, Zhou T, Nadeau-Vallee M, Hou X, Lavoie JC, Mitchell G, Mamer OA, Chemtob S: G-protein-coupled receptor 91 and succinate are key contributors in neonatal postcerebral hypoxia-ischemia recovery. Arterioscler Thromb Vasc Biol 2014; 34: 285-293.
34. Ariza AC, Deen PM, Robben JH: The succinate receptor as a novel therapeutic target for oxidative and metabolic stress-related conditions. Front Endocrinol (Lausanne) 2012; 3: 22.
35. Wang ZJ, Liang CL, Li GM, Yu CY, Yin M: Neuroprotective effects of arachidonic acid against oxidative stress on rat hippocampal slices. Chem Biol Interact 2006; 163: 207-217.
36. Darios F, Davletov B: Omega-3 and omega-6 fatty acids stimulate cell membrane expansion by acting on syntaxin 3. Nature 2006; 440: 813-817.
37. Petty F, Kramer G, Feldman M: Is plasma GABA of peripheral origin? Biol Psychiatry 1987; 22: 725-732.
38. Arrue A, Davila R, Zumarraga M, Basterreche N, Gonzalez-Torres MA, Goienetxea B, Zamalloa MI, Anguiano JB, Guimon J: GABA and homovanillic acid in the plasma of schizophrenic and bipolar I patients. Neurochem Res 2010; 35: 247-253.
39. Pearl PL, Shukla L, Theodore WH, Jakobs C, Michael Gibson K: Epilepsy in succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism. Brain Dev 2011; 33: 796-805.
40. Russo AJ: Correlation between hepatocyte growth factor (HGF) and gamma-aminobutyric acid (GABA) plasma levels in autistic children. Biomarker Insights 2013; 8: 69-75.
41. Lakhani R, Vogel KR, Till A, Liu J, Burnett SF, Gibson KM, Subramani S: Defects in GABA metabolism affect selective autophagy pathways and are alleviated by mTOR inhibition. EMBO Mol Med 2014; 6: 551-566.
42. Xie ZX, Xia SF, Qiao Y, Shi YH, Le GW: Effect of GABA on oxidative stress in the skeletal muscles and plasma free amino acids in mice fed high-fat diet. J Anim Physiol Anim Nutr 2014, Epub ahead of print.
43. Thomas RH, Meeking MM, Mepham JR, Tichenoff L, Possmayer F, Liu S, MacFabe DF: The enteric bacterial metabolite propionic acid alters brain and plasma phospholipid molecular species: further development of a rodent model of autism spectrum disorders. J Neuroinflammation 2012; 9: 153.